Adverse Drug Reaction Associated with Vitamins: An Analysis of Spontaneous Reports from Pharmacovigilance Programme of India Database
Abstract
The objective of this study was to describe adverse events with the use vitamins and to identify risk factors. A retrospective study was carried out from the spontaneous adverse drug reaction (ADR) reports for the period April 2011 to March 2013 by National Coordination Centre, Pharmacovigilance Programme of India (PvPI). 29 reports of vitamins were received by NCC-PvPI, which comprised approximately 0.064% of the total 45,297 reports received at NCC-PvPI. Among the different types of vitamins for which ADRs have been reported are vitamin A (11.43%), vitamin D (22.86%), vitamin E (14.28%), vitamin K (22.86%), vitamin B-complex (25.71%) and vitamin C (2.86%). Out of these 29 reports, 17 (58.62%) were of females and 12 (41.38%) of males. Only four cases (13.79%) were reported to be serious and rest of the cases (86.21%) were non-serious. Most of the reactions reported were recovered with 32%. The causality assessment of each ADR observed due to vitamin was done as per WHO-UMC. Vitamins are just like any other healthcare intervention – they have potential risks and benefits and it is best to follow the evidence.
Keywords: vitamin supplement, adverse drug reaction, health effects
Cite this Article
Kalaiselvan Vivekanandan, Kumar Ranvir, Thota Prasad et al. Adverse drug reaction associated with vitamins: An analysis of spontaneous reports from pharmacovigilance programme of India database. Research & Reviews: Journal of Pharmacology. 2015; 5(3): 12–18p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |